Implication of the GABA(B) receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine

Synapse

Volumn 31, Issue 2, 1999, Pages 151-153

  Ashby Jr , Charles R ^a   Rohatgi, Ruchi ^b   Ngosuwan, Jantra ^b   Borda, Tania ^b   Gerasimov, Madina R ^b   Morgan, Alexander E ^b   Kushner, Stephanie ^c   Brodie, Jonathan D ^c   Dewey, Stephen L ^b,c  

^a ST JOHN'S UNIVERSITY   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Dopamine; GABA(A) receptor; GABA(B) antagonist (SCH 50911); GABA(B) receptor; Gamma vinyl GABA (GVG, Vigabatrin ); Microdialysis; Nucleus accumbens; Positron emission tomography (PET)

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; COCAINE; DOPAMINE; VIGABATRIN;

ANIMAL TISSUE; ARTICLE; DOPAMINE BRAIN LEVEL; DRUG DEPENDENCE; DRUG EFFECT; DRUG RECEPTOR BINDING; LOCOMOTION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIMATE; PRIORITY JOURNAL; RAT;

EID: 0344628695     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199902)31:2<151::AID-SYN8>3.0.CO;2-W     Document Type: Article

References (16)

1. Bolser DC, Blythin DJ, Chapman RW, Egan RW, Hey JA, Rizzo C, Kuo S-C, Kreutner W. 1995. The pharmacology of SCH 50911: A novel, orally-active GABA-B receptor antagonist. J Pharmacol Exp Ther 274:1393-1398.
2. Dewey SL, Chaurasia CS, Chen C, Volkow ND, Clarkson FA, Porter SP, Straughter-Moore RM, AlexofT DL, Tedeschi D, Russo NB, Fowler JS, Brodie JD. 1997. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse 25:393-398.
3. Dewey SL, Morgan AE, Ashby CR Jr, Horan B, Kushner SA, Logan J, Volkow ND, Fowler JS, Gardner EL, Brodie JD. 1998. A novel strategy for the treatment of cocaine addiction. Synapse 30:119-129.
4. Di Chiara G, Imperato A. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
5. Ikemoto S, Kohl RR, McBride WJ. 1997. GABAa receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J Neurochem 69:137-143.
6. Kalivas PW, Duffy P, Eberhardt H. 1990. Modulation of 10 dopamine neurons by γ-aminobutyric acid agonists. J Pharmacol Exp Ther 253:858-866.
7. Kushner SA, Dewey SL, Kornetsky C. 1997a. Comparison of the effects of vigabatrin on cocaine self-administration and food reinforcement. Soc Neuro Abstr 23:1942.
8. Kushner SA, Dewey SL, Kornetsky C. 1997b. Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds. Psychopharmacology 133:383-388.
9. Lippert B, Metcalf BW, Jung MJ, Casara P. 1977. 4-Amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. Eur J Pharmacol 74:441-445.
10. Mattson RH, Petroff OA, Rothman D, Bebar K. 1995. Vigabatrin: Effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy. Acta Neurolog Scand Suppl 162:27-30.
11. Morgan AE, Dewey SL. 1998. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28:60-65.
12. Nazzaro J, Gardner EL. 1980. GABA antagonism lowers self-stimulation thresholds in the ventral tegmental area. Brain Res 189:279-283.
13. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. San Diego: Academic Press.
14. Roberts DC, Andrews MM. 1997. Baclofen suppression of cocaine self-administration: Demonstration using a discrete trials procedure. Psychopharmacology 131:271-277.
15. Roberts DC, Andrews MM, Vickers GJ. 1996. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15:417-423.
16. Westerink BHC, Kwint H-F, de Vries JB. 1996. Neuropharmacology of mesolimbic dopamine neurons: Dual-probe microdialysis in the ventral tegmental area and nucleus accumbens of the rat brain. J Neurosci 16:2605-2611.